Harvard Bioscience Inc (HBIO) — Net Asset Quality Index
Harvard Bioscience Inc (HBIO) has a Net Asset Quality Index of 18.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $77.99 Million minus total liabilities of $63.92 Million yields net assets of $14.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Harvard Bioscience Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Harvard Bioscience Inc Net Asset Quality Index Over Time (1998–2024)
This chart shows how Harvard Bioscience Inc's Net Asset Quality Index has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the index stands at 18.0%, representing net assets of $14.07 Million against total assets of $77.99 Million USD. See HBIO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Harvard Bioscience Inc (1998–2024)
The table below presents the year-by-year Net Asset Quality Index for Harvard Bioscience Inc from 1998 to 2024, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HBIO company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.0% | $63.34 Million | $126.64 Million | $63.30 Million | ▼ -3.2 pp |
| 2023 | 53.2% | $73.07 Million | $137.37 Million | $64.29 Million | ▲ +3.5 pp |
| 2022 | 49.7% | $72.22 Million | $145.36 Million | $73.14 Million | ▼ -1.7 pp |
| 2021 | 51.4% | $83.40 Million | $162.34 Million | $78.94 Million | ▲ +2.3 pp |
| 2020 | 49.1% | $76.68 Million | $156.25 Million | $79.57 Million | ▼ -0.5 pp |
| 2019 | 49.6% | $81.69 Million | $164.87 Million | $83.18 Million | ▲ +0.7 pp |
| 2018 | 48.9% | $82.18 Million | $168.07 Million | $85.89 Million | ▼ -25.1 pp |
| 2017 | 74.0% | $80.90 Million | $109.35 Million | $28.45 Million | ▲ +7.0 pp |
| 2016 | 67.0% | $72.20 Million | $107.77 Million | $35.57 Million | ▲ +2.4 pp |
| 2015 | 64.5% | $77.60 Million | $120.22 Million | $42.62 Million | ▼ -5.7 pp |
| 2014 | 70.2% | $95.47 Million | $135.92 Million | $40.45 Million | ▲ +0.5 pp |
| 2013 | 69.8% | $94.48 Million | $135.46 Million | $40.98 Million | ▼ -8.3 pp |
| 2012 | 78.1% | $104.21 Million | $133.48 Million | $29.27 Million | ▲ +2.7 pp |
| 2011 | 75.4% | $95.50 Million | $126.63 Million | $31.14 Million | ▲ +3.1 pp |
| 2010 | 72.3% | $90.25 Million | $124.80 Million | $34.55 Million | ▲ +2.1 pp |
| 2009 | 70.2% | $75.26 Million | $107.23 Million | $31.97 Million | ▼ -11.9 pp |
| 2008 | 82.1% | $66.72 Million | $81.27 Million | $14.55 Million | ▲ +7.1 pp |
| 2007 | 75.0% | $74.14 Million | $98.85 Million | $24.72 Million | ▼ -2.1 pp |
| 2006 | 77.1% | $71.88 Million | $93.23 Million | $21.34 Million | ▲ +2.8 pp |
| 2005 | 74.3% | $68.42 Million | $92.03 Million | $23.62 Million | ▼ -0.3 pp |
| 2004 | 74.6% | $104.36 Million | $139.88 Million | $35.52 Million | ▼ -2.4 pp |
| 2003 | 77.0% | $98.88 Million | $128.43 Million | $29.55 Million | ▼ -5.2 pp |
| 2002 | 82.2% | $88.38 Million | $107.58 Million | $19.20 Million | ▲ +1.0 pp |
| 2001 | 81.1% | $66.81 Million | $82.36 Million | $15.55 Million | ▼ -7.9 pp |
| 2000 | 89.0% | $52.33 Million | $58.81 Million | $6.47 Million | ▲ +50.3 pp |
| 1999 | 38.7% | $7.98 Million | $20.61 Million | $12.63 Million | ▲ +29.3 pp |
| 1998 | 9.4% | $678.00K | $7.22 Million | $6.54 Million | — |